KPV · Recovery
KPV dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (250 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 156–211 mcg | 0.16–0.21 mL | 6–8 units0.06–0.08 mL | – |
| 60–75 kg / 132–165 lb | 191–259 mcg | 0.19–0.26 mL | 8–10 units0.08–0.10 mL | – |
| 75–90 kg / 165–198 lb | 234–316 mcg | 0.23–0.32 mL | 9–13 units0.09–0.13 mL | – |
| 90–105 kg / 198–231 lb | 276–374 mcg | 0.28–0.37 mL | 11–15 units0.11–0.15 mL | – |
| >105 kg / >231 lb | 319–431 mcg | 0.32–0.43 mL | 13–17 units0.13–0.17 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for KPV; the elapsed-time column is hidden.
KPV by goal
Read KPV's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the KPV bibliography for relevance to dosing and pharmacokinetics.
- Self-Cross-Linked Hydrogel of Cysteamine-Grafted gamma-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.